DNA Chips, Biochips or DNA microarrays consists of a microscope slide made materials such as glass, silicon chips, and nylon membrane, which is printed with thousands of minute spots. These spots contain a known DNA sequence or gene in an orderly sequence. DNA microarray uses nucleic acid hybridization principle and type of DNA microarrays include cDNA microarrays, Oligo DNA microarrays, BAC microarrays, and SNP microarrays. Applications of DNA chips include study of transcriptomes and proteomes, diagnosis of diseases, identification of microbes, and others
The high cost involved in R&D of DNA/Gene microarray technology-based products and limited financial support has posed a great challenge to growth of the global DNA/Gene microarray market. Manufacturing complexity of the biochip technology and research and development that is required to bring out innovative biochips in the market results in high costs of these products.
- This report provides in-depth analysis of the global DNA/Gene microarray market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2026–2033), considering 2025, as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
- It profiles leading players in the global DNA/Gene microarray market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Affymetrix, Inc., Illumina, Inc., Agilent Technologies Inc., Roche NimbleGen Inc., Sequenom, Inc., Biometrix Technology Inc., LC Sciences, Life Technologies Corp., Lifegen Technologies LLC, Microarrays Inc..
- Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
- The global DNA/Gene microarray market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
-
- Oligonucleotide DNA Microarrays
- Complementary DNA Microarrays
-
- Genomics
- Proteomics
- Agricultural Biology
- Environment
- Drug Research and Development
- Cancer/oncology
- Others (SNP Analysis, etc.)
-
- Biopharmaceutical and Pharmaceutical Companies
- Diagnostic Laboratories
- Research Laboratories
- Others (Academic Institutes, etc.)
-
- North America
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
-
- Affymetrix, Inc.
- Illumina, Inc.
- Agilent Technologies Inc.
- Roche NimbleGen Inc.
- Sequenom, Inc.
- Biometrix Technology Inc.
- LC Sciences
- Life Technologies Corp.
- Lifegen Technologies LLC
- Microarrays Inc.
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- Caliper Life Sciences
- Perkin Elmer, Inc.
- PathogenDx, Inc.
- Twist Bioscience Corporation
- Arraylt Corporation
- Molecular Device, LLC
- Raybiotech Inc.
